PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 107 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 4.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $214,000 | -36.9% | 52,876 | -32.6% | 0.01% | -65.9% |
| Q3 2019 | $339,000 | +24.2% | 78,438 | +14.6% | 0.04% | +20.6% |
| Q2 2019 | $273,000 | -25.6% | 68,438 | 0.0% | 0.03% | -32.0% |
| Q1 2019 | $367,000 | -17.5% | 68,438 | -21.1% | 0.05% | -19.4% |
| Q4 2018 | $445,000 | -32.0% | 86,722 | +28.6% | 0.06% | -33.3% |
| Q3 2018 | $654,000 | +11.6% | 67,438 | +17.4% | 0.09% | +19.2% |
| Q2 2018 | $586,000 | -21.6% | 57,438 | 0.0% | 0.08% | -18.8% |
| Q1 2018 | $747,000 | – | 57,438 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,609,398 | $7,821,000 | 1.64% |
| Telemetry Investments, L.L.C. | 242,514 | $1,179,000 | 1.59% |
| Omega Fund Management, LLC | 2,606,809 | $12,669,000 | 1.42% |
| Bruce & Co., Inc. | 1,343,312 | $6,528,000 | 1.39% |
| 1492 Capital Management LLC | 488,309 | $2,373,000 | 1.20% |
| Abingworth LLP | 1,041,131 | $5,060,000 | 1.15% |
| Trellus Management Company, LLC | 295,000 | $1,434,000 | 1.04% |
| Worth Venture Partners, LLC | 389,440 | $1,893,000 | 0.85% |
| CM Management, LLC | 200,000 | $972,000 | 0.72% |
| GENERAL AMERICAN INVESTORS CO INC | 1,112,658 | $5,408,000 | 0.46% |